The plasma microparticle proteome

Kristina M Little1, David M Smalley, Nancy L Harthun

  • 1Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.

Insights

Plasma microparticles (MPs) contain proteins that may serve as disease biomarkers. This study identified a core set of 130 proteins in human plasma MPs, offering potential for diagnostic applications.

Area of Science:

  • Biochemistry
  • Proteomics
  • Clinical Diagnostics

Background:

  • Cellular activation or stress leads to shedding of microparticles (MPs), including ectosomes and exosomes.
  • Plasma MP protein composition is altered in various diseases, such as cardiovascular conditions, diabetes, sepsis, and sickle cell disease.
  • Normal human plasma contains approximately 2 μg MP protein/mL.

Purpose of the Study:

  • To characterize the protein composition of plasma microparticles.
  • To identify a core set of plasma MP proteins and investigate their correlation with patient demographics.
  • To evaluate the potential of the plasma MP proteome as a source of disease biomarkers.

Main Methods:

  • Label-free liquid chromatography coupled to tandem mass spectrometry was used to analyze plasma MP protein composition.
  • High-confidence protein identification was achieved using SEQUEST XCor criteria.
  • Analysis was performed on plasma samples from 42 patients, predominantly with cardiovascular disease.

Main Results:

  • A total of 458 proteins were detected with high confidence in plasma MPs.
  • A core set of 130 proteins was identified, consistently present across most patients.
  • This core proteome is enriched in cytoskeletal, integrin complex, and hemostasis proteins.
  • Spectral counts of some proteins correlated with patient age and gender.

Conclusions:

  • The proteome of plasma microparticles represents a valuable and dependable source of biologically relevant disease biomarkers.
  • The identified core set of MP proteins provides a foundation for further biomarker discovery.
  • Plasma MP analysis holds promise for advancing diagnostic capabilities in various diseases.